NovoCure Ltd Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2018 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
NovoCure Ltd quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2018 to Q3 2024.
- NovoCure Ltd Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 108M shares, a 1.38% increase year-over-year.
- NovoCure Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 106M shares, a 1.65% increase from 2022.
- NovoCure Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 105M shares, a 1.19% increase from 2021.
- NovoCure Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 103M shares, a 5% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)